CD274 and hepatocellular carcinoma: In metabolic subtypes such as steatotic HCC, the immune landscape is similarly characterized by T-cell exhaustion, infiltration of M2-like macrophages, and dense stromal content, yet paradoxically, these tumors express high levels of PD-L1, suggesting they may still benefit from ICB therapy [156].